Incyte Corp. (INCY)
128.01
-0.82
(-0.64%)
USD |
NASDAQ |
Sep 03, 16:00
128.16
+0.15
(+0.12%)
After-Hours: 20:00
Incyte Price : 128.01 for Sept. 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 02, 2026 | 126.43 | 129.56 | 125.89 | 128.83 | 2.324M |
| Sep 01, 2026 | 124.61 | 125.14 | 122.50 | 125.01 | 1.192M |
| Aug 31, 2026 | 122.66 | 124.00 | 121.61 | 123.22 | 1.483M |
| Aug 28, 2026 | 127.74 | 127.74 | 123.08 | 124.37 | 1.215M |
| Aug 27, 2026 | 128.13 | 128.20 | 126.06 | 127.74 | 700682.0 |
| Aug 26, 2026 | 129.18 | 129.54 | 127.77 | 128.12 | 800284.0 |
| Aug 25, 2026 | 128.98 | 130.80 | 127.50 | 129.72 | 1.162M |
| Aug 24, 2026 | 127.47 | 128.36 | 126.31 | 127.98 | 799608.0 |
| Aug 21, 2026 | 126.45 | 129.92 | 125.60 | 127.81 | 1.367M |
| Aug 20, 2026 | 127.10 | 129.80 | 126.71 | 127.22 | 1.207M |
| Aug 19, 2026 | 125.00 | 129.56 | 124.60 | 128.47 | 1.589M |
| Aug 18, 2026 | 124.29 | 124.74 | 123.23 | 123.47 | 1.191M |
| Aug 17, 2026 | 120.16 | 124.06 | 119.64 | 123.50 | 2.041M |
| Aug 14, 2026 | 119.15 | 120.44 | 117.56 | 120.16 | 785830.0 |
| Aug 13, 2026 | 122.23 | 122.23 | 119.71 | 120.52 | 829464.0 |
| Aug 12, 2026 | 119.54 | 121.57 | 118.88 | 120.77 | 1.055M |
| Aug 11, 2026 | 121.13 | 122.28 | 120.06 | 121.07 | 1.080M |
| Aug 10, 2026 | 120.56 | 122.69 | 120.50 | 121.55 | 1.352M |
| Aug 07, 2026 | 118.56 | 120.88 | 117.38 | 120.56 | 1.540M |
| Aug 06, 2026 | 119.80 | 120.29 | 115.77 | 118.38 | 2.390M |
| Aug 05, 2026 | 123.99 | 124.57 | 119.52 | 119.80 | 1.796M |
| Aug 04, 2026 | 119.08 | 120.93 | 117.00 | 120.60 | 2.078M |
| Aug 03, 2026 | 120.22 | 121.37 | 118.02 | 118.43 | 1.419M |
| Jul 31, 2026 | 122.75 | 122.75 | 118.44 | 119.52 | 1.830M |
| Jul 30, 2026 | 123.99 | 126.50 | 121.63 | 122.99 | 2.628M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Mirum Pharmaceuticals, Inc. | 100.60 |
| Regeneron Pharmaceuticals, Inc. | 843.57 |
| Eli Lilly & Co. | 1159.50 |
| AbbVie, Inc. | 260.14 |
| Biogen, Inc. | 224.41 |
Price Related Metrics
| PE Ratio | 16.31 |
| PS Ratio | 4.516 |
| PEG Ratio | 0.2082 |
| Price to Book Value | 4.055 |
| Price to Free Cash Flow | 13.90 |
| Earnings Yield | 6.13% |
| Market Cap | 25.73B |
| PEGY Ratio | 0.2082 |
| Operating PE Ratio | 14.29 |
| Normalized PE Ratio | 16.06 |